Dupont Capital Management’s Orion Biotech Opportunities Corp. Warrant ORIAW Stock Holding History

Dupont Capital Management’s Portfolio ORIAW Stock Details ORIAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-20,000	Closed	-$1.41K	–	780
2023 Q1	$1.41K	Hold	20,000	–	–	﹤0.01%	659
2022 Q4	$3.27K	Hold	20,000	–	–	﹤0.01%	1208
2022 Q3	$4K	Hold	20,000	–	–	﹤0.01%	1355
2022 Q2	$3K	Hold	20,000	–	–	﹤0.01%	1511
2022 Q1	$7K	Hold	20,000	–	–	﹤0.01%	1568
2021 Q4	$19K	Hold	20,000	–	–	﹤0.01%	1545
2021 Q3	$18K	Buy	+20,000	New	+$26K	﹤0.01%	1557

Dupont Capital Management's ORIAW Position: Q2 2023 in Review

Dupont Capital Management sold out of Orion Biotech Opportunities Corp. Warrant (ORIAW) in Q2 2023, closing a stake of 20,000 shares — an estimated $1.41K sold.

Dupont Capital Management first reported a position in ORIAW in Q3 2021 and held it in 7 quarters. The position peaked at $19K in Q4 2021. 0 funds tracked by Wall St. Rank hold ORIAW as of Q2 2023.

Dupont Capital Management reported no remaining Orion Biotech Opportunities Corp. Warrant position as of Q2 2023 after selling out during the quarter.
Dupont Capital Management sold 20,000 Orion Biotech Opportunities Corp. Warrant shares in Q2 2023, an estimated $1.41K.
Dupont Capital Management first reported a position in Orion Biotech Opportunities Corp. Warrant in Q3 2021 and held it in 7 quarters.
Dupont Capital Management's Orion Biotech Opportunities Corp. Warrant position peaked at $19K in Q4 2021.
0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Warrant as of Q2 2023.

Based on Dupont Capital Management's 13F filing for Q2 2023, filed 25 Jul 2023.